We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.75 | -3.53% | 20.50 | 20.00 | 21.00 | 21.25 | 20.50 | 21.25 | 875,556 | 14:55:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.46 | 53.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/10/2022 18:37 | Antagonis. You are an idiot. Check my posts. Having not bought any more for many months I bought about £8k more in the last week or so. So once again grow up you moron. | purchaseatthetop | |
07/10/2022 18:00 | Unnecessary vulgar language from PURCHASEATTHETOP. There’s no need to lie as it doesn’t impress anyone. It’s frankly embarrassing. If we add up every alleged buy PURCHASE has posted about he’s now on well over 1 million shares. And him responding with foul language only shows his true colours to those intelligent enough to see it. | antonagis | |
07/10/2022 17:54 | For anyone thinking of gambling on what is now a mid to high risk stock like this, probably best to wait till we are deep in recession. Whatever anyone says that will affect even companies like AGL. Add that to having AN running the business side and you’ve got 50p or less on the way. If this drops under 60p I think that’s the point where it will then just continue to drift. Based on some of the posts on here we’ve got a couple of people allegedly buying week in week out. By now they must be majority shareholders! | antonagis | |
07/10/2022 17:23 | Now they have the Ovarian results, which were excellent, and some clear indication on similar in prostate, head/neck throat etc alongside FDA approval in Breast cancer, that a larger partnership will be being worked on currently. Might be Abbott, but as likely to be one of the other key players who will run any trials needed to add to FDA for other companion diagnostic tests and a real differentiator. | waterloo01 | |
07/10/2022 17:15 | It's going to be a long old winter, without some further positive updates on partnerships, JV's etc. | tday | |
07/10/2022 16:57 | AGL Red :(EUA Blue :) | 1liam | |
07/10/2022 15:40 | Still a long way to drop. | 1liam | |
07/10/2022 15:27 | To think Andrew was only a few months ago making it clear he only wanted certain types of shareholders that shared his philanthropic vision and would be i it for the very long haul (decades, not several years) - then tapped the market a few weeks later when reality hit home. | yasx | |
07/10/2022 14:04 | The full Jefferies note is on the Telegram board: | sicilian_kan | |
07/10/2022 14:01 | Market shaker, also they forgot to say that the ceo also came out with a horrific video interview where he said something like "he doesn't care about his shareholders" and that they "should not expect big rewards" then he went and raised money at 80p!! | jibba jabber | |
07/10/2022 13:45 | Patience will be handsomely rewarded | spaceparallax | |
07/10/2022 13:36 | So seller(s) not convinced by the presentations and strategy of path to profitability. Unfortunately, Only hard sales figures and major partnerships will do it appears! | ramnik007 | |
07/10/2022 11:32 | It’s 65.0/65.35 right now so all trades are seen as sells as spread is 65/66 and both are under 65.5. Just ignore the buy/sell. | purchaseatthetop | |
07/10/2022 11:29 | Buy/sell is a guess based on the trade price. If the trade is below the mid point of the quotes at the time it's marked as a sell, if it's above it's marked as a buy How can it be made more accurate | asdb9 | |
07/10/2022 10:31 | 15000 was a buy - it's always happening .What is the point of the chart if not accurate ? | roysta | |
07/10/2022 09:56 | Marketshaker. The market wants to see the first path to cash flow and revenues and once that happens this will fly. It is very very risk averse right now. Fairly soon we should also get lab certification. I am adding here now as next year the game will be completely different. Just my view. | purchaseatthetop | |
07/10/2022 09:25 | LTH here. First bought into Agl at Xmas 2009. Been patient. FDA was the goal then. Once we got FDA clearance, I thought that would be the base for the share price., 1.60. There is no way this should be lower than that. Can anyone explain what has happened since May? Trying to be patient but slowly running out of reasons to stay | marketshaker | |
07/10/2022 08:40 | The 55 to 365 scale tells you this ! | amaretto1 | |
07/10/2022 08:39 | Yes iam .... it's a opportunity you don't get often ...Jefferies have no clue what's been talked about with Abbot It could be a partnership....The share price would go in to orbit if true I'm going to add 15k today I'll put money were my mouth is !! | amaretto1 | |
07/10/2022 08:34 | Look at the share price, the man doesn't know how to court the market, if he did he wouldn't have raised at 80p post FDA clearance. | jibba jabber | |
07/10/2022 08:29 | I wonder if the CEO has been taking advice from Gerald Ratner. Remember him and his famous quote? | 1liam |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions